GPS Wealth Strategies Group, LLC - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 1 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GPS Wealth Strategies Group, LLC ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$142,000
-29.0%
58,025
+18.4%
0.04%
-31.4%
Q2 2021$200,000
-5.7%
49,025
+4.3%
0.05%
-17.7%
Q1 2021$212,000
-6.2%
47,025
+2.2%
0.06%
-21.5%
Q4 2020$226,000
-16.3%
46,025
+1.2%
0.08%
-27.5%
Q3 2020$270,00045,5000.11%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 4,172,459$24,743,0002.02%
Kamunting Street Capital Management, L.P. 345$2,046,0001.28%
DELTEC ASSET MANAGEMENT LLC 853,132$5,059,0000.90%
Alpine Global Management, LLC 552,856$3,278,0000.68%
Kamunting Street Capital Management, L.P. 100,000$593,0000.37%
Redmile Group, LLC 2,397,441$14,217,0000.26%
IHT Wealth Management, LLC 207,210$1,229,0000.12%
ArrowMark Colorado Holdings LLC 2,075,387$12,307,0000.12%
GPS Wealth Strategies Group, LLC 45,500$270,0000.11%
683 Capital Management, LLC 233,600$1,385,0000.10%
View complete list of XERIS PHARMACEUTICALS INC shareholders